2014
DOI: 10.3892/ol.2014.2611
|View full text |Cite
|
Sign up to set email alerts
|

Cantharidin induces G2/M phase arrest and apoptosis in human gastric cancer SGC-7901 and BGC-823 cells

Abstract: The aim of the present study was to investigate the effect of cantharidin (CTD) on human gastric cancer cells and to explore the underlying mechanisms of these effects. The human gastric cancer SGC-7901 and BGC-823 cell lines were treated with CTD. MTS assays were then employed to examine cellular proliferation, flow cytometry was used to analyze the cell cycle and apoptosis, and western blot analysis was used to determine protein expression levels. It was found that CTD inhibited the proliferation of the huma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
23
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 33 publications
(28 citation statements)
references
References 32 publications
5
23
0
Order By: Relevance
“…Previous studies have reported that CTD efficiently inhibited proliferation and induced apoptosis in various cancer cells, including oral squamous cell carcinoma, renal carcinoma and gastric cancer cells (18)(19)(20). The results of the present study also demonstrated that CTD inhibited A549 cell proliferation and migration, which is consistent with the results of previous studies (18)(19)(20).…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Previous studies have reported that CTD efficiently inhibited proliferation and induced apoptosis in various cancer cells, including oral squamous cell carcinoma, renal carcinoma and gastric cancer cells (18)(19)(20). The results of the present study also demonstrated that CTD inhibited A549 cell proliferation and migration, which is consistent with the results of previous studies (18)(19)(20).…”
Section: Discussionsupporting
confidence: 93%
“…The results of the present study also demonstrated that CTD inhibited A549 cell proliferation and migration, which is consistent with the results of previous studies (18)(19)(20). The combined results of these studies provide evidence that CTD is a promising therapeutic candidate for the treatment of NSCLC.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Cantharidin (CTD) is a type of terpenoid extracted from the traditional Chinese medicine mylabris ( blister beetle ). CTD and its demethylated analogue, norcantharidin (NCTD), were reported to induce G2/M cell cycle arrest and apoptosis in many human solid tumor cells such as hepatocellular carcinoma, pancreatic cancer, prostate cancer, gastric cancer, colon cancer, bladder carcinoma, breast cancer, oral carcinoma, esophageal carcinoma, and melanoma . In contrast to solid tumor cells, the anti‐leukemic effects of CTD and NCTD were also documented .…”
Section: Introductionmentioning
confidence: 99%
“…Normal cells will cycle through checkpoints signaling pathways to ensure cells have time to repair damaged DNA (Orren et al, 1997). There have been earlier reports of CTD inducing apoptotic cell death in different human cancer cell lines such as colorectal carcinoma cells (Peng et al, 2001), hepatoma cells (Chen et al, 2002), bladder carcinoma cells (Huan et al, 2006), multiple myeloma cells (Sagawa et al, 2008) and lung cancer cells (Hisa et al, 2014b) and gastric cancer cells (Zhang et al, 2014). It was also reported that CTD inhibited cell migration and invasion of human bladder carcinoma cells (Huang et al, 2013).…”
Section: Discussionmentioning
confidence: 99%